April 3, 2017 Health and Biotech analytics news roundup

Advantages of a Truly Open-Access Data-Sharing Model: Traditionally, data from clinical trials has been siloed, but now there is support for making such data open for all to use. Project Data Sphere is one such effort.

Detecting mutations could lead to earlier liver cancer diagnosis: Aflatoxin induces a mutation that can cause liver cancer. Now, MIT researchers have developed a method to detect this mutation before cancer develops.

Australia launches machine-learning centre to decrypt the personal genome: Geneticists and computer scientists have launched the Garvan-Deakin Program in Advanced Genomic Investigation (PAGI). They hope to work out the complex genetic causes of diseases.

More genomic sequencing announced for Victoria: Selected Australian patients will have access to genomic sequencing. This project is intended to help track drug-resistant “superbugs” as well as 4 other personalized conditions.

No, We Can’t Say Whether Cancer Is Mostly Bad Luck: Last week’s news on the mutations that cause cancer is disputed among cancer scientists.

Source: April 3, 2017 Health and Biotech analytics news roundup by pstein

Leave a Reply

Your email address will not be published. Required fields are marked *